TCL Archive After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big December 2, 2011
TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
TCL Archive Chemotherapy Pioneer Howard Skipper Dead; His Work With Lekemia Cells In Mice Led To Development of Combination Therapies. January 13, 2006
TCL Archive In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director March 17, 1995
TCL Archive DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes March 4, 1988
